1. Home
  2. RFL vs RAND Comparison

RFL vs RAND Comparison

Compare RFL & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$1.18

Market Cap

54.4M

Sector

Finance

ML Signal

HOLD

Logo Rand Capital Corporation

RAND

Rand Capital Corporation

HOLD

Current Price

$11.35

Market Cap

41.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RFL
RAND
Founded
2017
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Finance: Consumer Services
Sector
Finance
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
54.4M
41.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RFL
RAND
Price
$1.18
$11.35
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
182.7K
11.3K
Earning Date
12-11-2025
11-07-2025
Dividend Yield
N/A
10.94%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,029,000.00
$7,327,287.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
47.63
N/A
52 Week Low
$1.15
$10.56
52 Week High
$3.19
$31.89

Technical Indicators

Market Signals
Indicator
RFL
RAND
Relative Strength Index (RSI) 40.44 33.43
Support Level $1.21 $10.56
Resistance Level $1.35 $17.49
Average True Range (ATR) 0.12 1.01
MACD -0.02 -0.55
Stochastic Oscillator 6.67 11.40

Price Performance

Historical Comparison
RFL
RAND

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About RAND Rand Capital Corporation

Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.

Share on Social Networks: